These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1305046)

  • 1. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours.
    Danilos J; Zbroja-Sontag W; Baran E; Kurylcio L; Kondratowicz L; Jusiak L
    Drugs Exp Clin Res; 1992; 18 Suppl():55-62. PubMed ID: 1305046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
    Lohninger A; Hamler F
    Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky.
    Pengsaa P; Wongpratoom W; Vatanasapt V; Udomthavornsuk B; Mairieng E; Tangvorapongchai V; Pesi M; Krusan S; Boonvisoot V; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():69-72. PubMed ID: 1305048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Brzosko WJ
    Drugs Exp Clin Res; 2000; 26(5-6):201-21. PubMed ID: 11345028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of Ukrain monotherapy of prostate cancer.
    Uglyanitsa KN; Nechiporenko NA; Nefyodov LI; Doroshenko YM; Brzosko W; Nowicky W
    Drugs Exp Clin Res; 2000; 26(5-6):191-3. PubMed ID: 11345026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain treatment in a patient with breast carcinoma. Case report.
    Zemskov SV; Prokopchuk OL; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):253-4. PubMed ID: 11345033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
    Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies of Ukrain in terminal cancer patients (phase II).
    Musianowycz J; Judmajer F; Manfreda D; Spängler P; Albrecht H; Hoffmann J; Meijer D
    Drugs Exp Clin Res; 1992; 18 Suppl():45-50. PubMed ID: 1305043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
    Uglyanitsa KN; Nefyodov LI; Brzosko V
    Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ukrain treatment of a patient with retroperitoneal synovial sarcoma. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):255-6. PubMed ID: 11345034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
    Fomin KA; Uglyanica KN; Nefyodov LI; Djurd TI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):143-5. PubMed ID: 8899318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors.
    Aschhoff B
    Drugs Exp Clin Res; 2000; 26(5-6):249-52. PubMed ID: 11345032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies.
    Uglianitsa KN; Nefyodov LI; Brzosko W
    Drugs Exp Clin Res; 1998; 24(5-6):231-9. PubMed ID: 10190080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters.
    Uglyanica KN; Fomin KA; Nefyodov LI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):135-8. PubMed ID: 8899316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):257-9. PubMed ID: 11345035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
    Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ukrain (NSC-631570) in experimental and clinical studies: a review.
    Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ukrain (NSC-631570) in the treatment of pancreas cancer.
    Zemskov VS; Procopchuk OL; Susak YM; Zemskov SV; Hodysh YY; Zemskova MV
    Drugs Exp Clin Res; 2000; 26(5-6):179-90. PubMed ID: 11345025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
    Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
    Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.